Immunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in combination with other treatments for stomach cancer. Immunotherapy is a treatment that helps the immune ...

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

A catheter for chemotherapy on a woman’s arm. Photo courtesy National Cancer Institute via Wikimedia Commons Music lovers around the world mourned the passing of Grammy award-nominee Toby Keith due to ...

Stomach ulcers and stomach cancer can both cause abdominal pain and other gastrointestinal symptoms, but there are some differences. Both conditions can be serious and require medical attention. The ...

Stomach cancer, also known as gastric cancer, begins in the cells that line the stomach. The vast majority of stomach cancers are the adenocarcinoma type, which affects the glandular mucus-producing ...

DDF acknowledges the critical support from industry partners that helped make the year a success. FORT LAUDERDALE, Fla., Dec. 30, 2025 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer ...

Stomach cancer, also called gastric cancer, develops when cells in the stomach lining begin to grow out of control. People usually don’t experience any symptoms in the early stages, which makes early ...

Adenocarcinoma is the most common form of stomach cancer. It can cause digestive issues and abdominal pain. Its causes stem from genetic, dietary, and lifestyle factors, while treatment ranges from ...

Screening is the process of checking for cancer before there are any warning signs or symptoms. The purpose of gastric cancer screening is to detect any changes in your stomach tissue at an early ...

Almost all stomach cancers are adenocarcinomas. But some rarer types may be more aggressive, affecting your treatment options and outlook. Stomach cancer (or gastric cancer) happens when cancerous ...

The days of broad approvals for PD-1 inhibitors in stomach and esophageal cancers appear to be numbered. A group of external advisers to the FDA voted 10-2 that the use of PD-1 inhibitors in ...